Anzemet (dolasetron)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anzemet (dolasetron), covering 2012-08-20 to 2012-08-20. Get the full timeline:
Most recent: Clinical Trial Update: Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension [NA]